\nProject: Precision medicine advancing renal transplantation.
![\"\"](\"\/wp-content\/uploads\/2024\/09\/22a56ad9-eca7-445b-9f6c-d4b4a6e382fb_222_329.jpeg\")
<\/p>\nDr Jennifer Li, Centre for Transplant and Renal Research, was awarded her PhD in 2023 and is a Staff Specialist Nephrologist and Transplant Physician at Westmead Hospital. Dr Li has won many awards including the 2019 Transplantation Society of Australia and New Zealand (TSANZ) President\u2019s Prize, and the 2022 TSANZ Early Career Science Award.<\/p>\n
<\/p>\n
<\/p>\n
Dr Najla Nasr<\/strong> The research program of Dr Najla Nasr, Centre for Virus Research, targets therapeutic strategies in the fight against HIV aiming at vaccine development, clearance of viral reservoirs and\/or limiting the establishment of latent CD4 T cells viral reservoirs that don\u2019t respond to antiretroviral therapy.<\/p>\n <\/p>\n <\/p>\n Professor Andrew Harman and Professor Scott Byrne<\/strong> Professor Andrew Harman, Deputy Director, Centre for Virus Research and Professor of Virology and Immunology in the University of Sydney School of Medical Sciences, has extensive collaborations with surgeons at Westmead Hospital who provide his research groups with a large range of human tissues with which he conducts all his research. He leads two research groups investigating sexual transmission of HIV and Inflammatory Bowel Diseases, such as Crohn’s Disease.<\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n Associate Professor Guoping Zheng<\/strong> Associate Professor Guoping Zheng leads the Kidney Injury Repair and Fibrosis group in the Centre for Transplant and Renal Research. He has made seminal contributions to the field of kidney fibrosis in DNA vaccine, MMPs and TGF-\u03b2 signaling.<\/p>\n <\/p>\n <\/p>\n Associate Professor Aaron Schindeler<\/strong> Associate Professor Schindeler heads the Bioengineering and Molecular Medicine laboratory at WIMR, in collaboration with The Children\u2019s Hospital at Westmead.\u00a0 Associate Professor Schindeler\u2019s research focuses on the development of new tools for functional genomics and gene therapy for bone fragility disorders; pharmaceutical modulation of bone healing; bone tissue engineering using new biomaterials and 3D printing; and treating the musculoskeletal complications associated with Neurofibromatosis type 1.<\/p>\n![\"\"](\"\/wp-content\/uploads\/2024\/09\/afa0500c-bad6-47e9-a529-936b0ed68b72.jpg\")
\nProject: A novel strategy to reactivate HIV in CD4 T cells via interferon alpha treatment.<\/p>\n
\nProject: Defining the role of antigen presenting cells in Crohn\u2019s Disease.![\"\"](\"\/wp-content\/uploads\/2024\/09\/31d3586e-0014-42f3-8a66-cb3b0c8eec21.jpg\")
<\/p>\n![\"\"](\"\/wp-content\/uploads\/2024\/09\/f17d90b4-cbf0-45bd-9888-ec85c05aca31-1-scaled.jpg\")
\nProfessor Scott Byrne is Co-Deputy Director, Centre for Immunology and Allergy Research, and co-leader of the Autoinflammatory Diseases Group, where his team are developing and testing novel immune-modulating drugs that could lead to breakthroughs in the treatment of diseases like psoriasis, dermatitis, wound healing, inflammatory bowel disease and Crohn\u2019s disease.<\/p>\n
\nProject: Preventing kidney failure using BMP-7 engineered macrophages in chronic![\"\"](\"\/wp-content\/uploads\/2024\/09\/2696486e-cbb8-4bf7-93e5-1627fc31cdd1.jpg\")
\nkidney disease.<\/p>\n
\nProject: Exploring gene therapy for Neurofibromatosis types 1 and 2.![\"\"](\"\/wp-content\/uploads\/2024\/09\/7184ea46-c186-4a24-8656-33d1f7128ab1.jpg\")
<\/p>\n